• Phase-I portion of study completed at the National Cancer Institute.
• Currently in Phase-II Clinical Trials in multiple clinical sites.

Click here for trial sites, eligibility criteria and study specifics.

HyperAcute® Prostate:

• Phase-I portion of study completed.
• Phase-II trials in planning stages.

Click here for trial sites, eligibility criteria and study specifics.

HyperAcute® Melanoma:

• Phase-I portion of study completed.
• Phase-II trials in planning stages.

Click here for trial sites, eligibility criteria and study specifics.

HyperAcute® Pancreas:

• Phase-I completed
• Currently in Phase-II clinical trials.

Click here for trial sites, eligibility criteria and study specifics.

Small Molecule :

• IND recently filed.
• Patient enrollment for Phase-I currently underway.